Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.

STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Tuesday 29 September →